These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biology and novel therapeutics for neuroendocrine tumors of the lung. Jafri N, Salgia R. J Biol Regul Homeost Agents; 2004 Jun; 18(3-4):275-90. PubMed ID: 15786694 [Abstract] [Full Text] [Related]
8. Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. Gazdar AF, Kadoyama C, Venzon D, Park JG, Tsai CM, Linnoila RI, Mulshine JL, Ihde DC, Giaccone G. J Natl Cancer Inst Monogr; 1992 Jun; (13):191-6. PubMed ID: 1327032 [Abstract] [Full Text] [Related]
9. Molecular genetic characterization of neuroendocrine lung cancer cell lines. Lai SL, Brauch H, Knutsen T, Johnson BE, Nau MM, Mitsudomi T, Tsai CM, Whang-Peng J, Zbar B, Kaye FJ. Anticancer Res; 1995 Jun; 15(2):225-32. PubMed ID: 7762988 [Abstract] [Full Text] [Related]
12. Carcinomas of the lung with neuroendocrine differentiation. Carter D, Yesner R. Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628 [Abstract] [Full Text] [Related]